Clinical Trial Update: A Multicenter, Randomized, Open-Label, Parallel-Controlled Clinical Study Comparing the Efficacy and Safety of Cofrogliptin Versus Acarbose in Drug-Naïve Patients With Type 2 Diabetes [NA]

View source ↗

Summary

This clinical trial update outlines a multicenter, randomized, open-label study comparing Cofrogliptin to acarbose in drug-naïve patients with type 2 diabetes, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Acarbose (acarbose)
• Cofrogliptin (Cofrogliptin)

Snippet

Sponsor: Haisco Pharmaceutical Group Co., Ltd. | Conditions: Type 2 Diabetes | NA | Status: NOT_YET_RECRUITING